News & Updates

Rochester, MN, USA—Resoundant, Inc. announced that the Food and Drug Administration (FDA) has awarded Mayo Clinic $250,000 to further advance liver stiffness as measured by magnetic resonance elastography (MRE) as a key biomarker for clinical trials into non-alcoholic steatohepatitis (NASH). The grant, entitled Systematic Analysis and Threshold Synthesis for |G*| as a Diagnostic Biomarker for NAFLD and NASH Clinical Trials, will leverage the large, published evidence base for